US Physical Therapy (USPH) Tops Q2 EPS by 1c, beats revenue
Tweet
Share
E-mailGet Alerts USPH Hot Sheet
Price: $79.35 +0.90%
Revenue Growth %: +8.5%
Financial Fact:
Provision for doubtful accounts: 917K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +8.5%
Financial Fact:
Provision for doubtful accounts: 917K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
US Physical Therapy (NYSE: USPH) reported Q2 EPS of $0.76, $0.01 better than the analyst estimate of $0.75. Revenue for the quarter came in at $151.49 million versus the consensus estimate of $151.06 million.
For earnings history and earnings-related data on US Physical Therapy (USPH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Geberit AG (GEBN:SW) (GBERY) PT Raised to CHF712 at Jefferies
- UBS Upgrades E.ON SE (EOAN:GR) (EONGY) to Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
